BioResearch Open Access, a bimonthly peer-reviewed open access journal, provides a new rapid-publication forum for a broad range of scientific topics including but not limited to molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience.
Article processing charges (APC) apply for articles submitted after November, 1, 2012.
The Journal publishes basic science and translational research in the form of original research articles, comprehensive review articles, mini-reviews, rapid communications, brief reports, technology reports, hypothesis articles, perspectives, and letters to the editor. All articles in BioResearch Open Access will be rapidly reviewed and published online within 4 weeks of acceptance. Articles will be fully open access and posted on PubMedCentral. BioResearch Open Access is fully NIH-, HHMI- and Wellcome Trust compliant.
Benefits to authors include:
- Experienced journal editors as Section Editors recommending articles for publication
- Rapid peer-review and publication within 4 weeks of acceptance
- No color art charges
- Global exposure in over 140 countries around the world
The new Journal is under the leadership of Editor-in-Chief Robert Lanza, MD, Advanced Cell Technology and Wake Forest University School of Medicine and seasoned journal editors as Section Editors. View the entire editorial board.
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.